NCT04629729 2026-03-19FT819 in Subjects With B-cell MalignanciesFate TherapeuticsPhase 1 Active not recruiting54 enrolled
NCT03914625 2026-03-18A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting6,720 enrolled
NCT03504644 2026-02-25Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic LeukemiaEastern Cooperative Oncology GroupPhase 1/2 Active not recruiting40 enrolled 18 charts